
According to data from Benzinga Pro, during Q1, Health Catalyst's (NASDAQ:HCAT) reported sales totaled $68.09 million. Despite a 54.16% increase in earnings, the company posted a loss of $22.46 million. Health Catalyst collected $64.72 million in revenue during Q4, but reported earnings showed a $48.99 million loss.